|
|
||||||||
Division of Cardiac Surgery and the Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital, Laboratory of Immunogenetics and Transplantation, Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02114
Despite increasing use of swine in transplantation
research, the ability to block costimulation of allogeneic T cell
responses has not been demonstrated in swine, and the effects of
costimulatory blockade on xenogeneic human anti-porcine T cell
responses are also not clear. We have compared the in vitro effects of
anti-human CD154 mAb and human CTLA4IgG4 on allogeneic pig T cell
responses and xenogeneic human anti-pig T cell responses. Both
anti-CD154 mAb and CTLA4IgG4 cross-reacted on pig cells. While
anti-CD154 mAb and CTLA4IgG4 both inhibited the primary allogeneic
pig MLRs, CTLA4IgG4 (7.88 µg/ml) was considerably more inhibitory
than anti-CD154 mAb (100 µg/ml) at optimal doses. Anti-CD154 mAb
inhibited the production of IFN-
by 75%, but did not inhibit IL-10
production, while CTLA4IgG4 completely inhibited the production of both
IFN-
and IL-10. In secondary allogeneic pig MLRs, CTLA4IgG4, but not
anti-CD154 mAb, induced Ag-specific T cell anergy. CTLAIgG4
completely blocked the indirect pathway of allorecognition, while
anti-CD154 mAb blocked the indirect response by approximately 50%.
The generation of porcine CTLs was inhibited by CTLA4IgG4, but not by
anti-CD154 mAb. Human anti-porcine xenogeneic MLRs were blocked
by CTLA4IgG4, but only minimally by anti-CD154 mAb. Finally,
CTLA4IgG4 prevented secondary xenogeneic human anti-porcine T cell
responses. These data indicate that blockade of the B7-CD28 pathway was
more effective than blockade of the CD40-CD154 pathway in inhibiting
allogeneic pig T cell responses and xenogeneic human anti-pig T
cell responses in vitro. These findings have implications for
inhibiting cell-mediated immune responses in pig-to-human
xenotransplantation.
This article has been cited by other articles:
![]() |
V. Mirenda, D. Golshayan, J. Read, I. Berton, A. N. Warrens, A. Dorling, and R. I. Lechler Achieving Permanent Survival of Islet Xenografts by Independent Manipulation of Direct and Indirect T-Cell Responses Diabetes, April 1, 2005; 54(4): 1048 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Costa, D. F. Barber, and W. L. Fodor Human NK Cell-Mediated Cytotoxicity Triggered by CD86 and Gal{alpha}1,3-Gal Is Inhibited in Genetically Modified Porcine Cells J. Immunol., April 15, 2002; 168(8): 3808 - 3816. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Lee, K. Yamada, S. L. Houser, K. L. Womer, M. E. Maloney, H. S. Rose, M. H. Sayegh, and J. C. Madsen Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy PNAS, March 13, 2001; 98(6): 3276 - 3281. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Lee, J. R. Rusche, M. E. Maloney, D. H. Sachs, M. H. Sayegh, and J. C. Madsen CTLA4Ig-Induced Linked Regulation of Allogeneic T Cell Responses J. Immunol., February 1, 2001; 166(3): 1572 - 1582. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |